Skip to main content
. 2023 Jul 31;44(1):35–40. doi: 10.1097/WNO.0000000000001959

TABLE 2.

Two-factors split-plot analysis of variance analysis

Two-Factors Split-Plot ANOVA
PD
N = 21 (41 eyes)
ET
N = 23 (42 eyes)
HC
N = 17 (33 eyes)
Model
F (P)
Groups
F (P)
Eye
F (P)
Groups × Eye
F (P)
Right Eye Left Eye Right Eye Left Eye Right Eye Left Eye
RNFL (µm) 13.6 ± 2.2 13.2 ± 1.6 15.0 ± 1.6 15.0 ± 1.7 17.9 ± 1.8 17.6 ± 2.5 19.76 (<0.001) 48.98 (< 0.001) 0.54 (0.463) 0.11 (0.9)
GCL (µm) 15.8 ± 3.4 16.4 ± 2.9 17.5 ± 3.7 17.6 ± 3.2 21.5 ± 2.3 21.4 ± 2.2 11.48 (<0.001) 28.41 (<0.001) 0.17 (0.684) 0.11 (0.9)
IPL (µm) 20.8 ± 3.5 21.9 ± 2.1 21.5 ± 3.2 22.7 ± 3.3 24.8 ± 1.6 23.6 ± 2.4 4.86 (<0.001) 9.48 (< 0.001) 0.5 (0.479) 2.04 (0.135)
INL (µm) 19.9 ± 6.5 21.6 ± 4.2 23.5 ± 5.4 23.5 ± 5.0 27.3 ± 4.7 29.1 ± 4.4 8.22 (<0.001) 19.5 (<0.001) 1.51 (0.222) 0.39 (0.675)
OPL (µm) 26.5 ± 6.8 30.5 ± 5.0 27.5 ± 5.9 28.4 ± 4.4 30.7 ± 3.2 31.7 ± 6.2 2.8 (0.02) 3.71 (0.027) 4.01 (0.05) 1.13 (0.327)
ONL (µm) 85.8 ± 15.6 86.4 ± 8.7 87.8 ± 10.3 86.9 ± 9.6 97.5 ± 7.0 97.9 ± 8.6 5.16 (<0.001) 12.84 (<0.001) 0.001 (0.99) 0.05 (0.947)
RPE (µm) 15.4 ± 1.9 15.7 ± 1.3 15.4 ± 1.6 16.0 ± 1.5 16.3 ± 1.8 16.2 ± 1.7 1.09 (0.368) 1.77 (0.174) 0.94 (0.334) 0.37 (0.688)
pRNFL (µm) 91.8 ± 10.4 93.8 ± 8.4 94.9 ± 10.3 96.0 ± 9.8 100.0 ± 6.8 102.3 ± 9.1 3.21 (0.01) 7.48 (<0.001) 1.07 (0.303) 0.05 (0.951)
pRNFL superior (µm) 109.8 ± 18.4 115.9 ± 14.0 114.0 ± 11.5 114.0 ± 11.2 119.6 ± 7.5 121.7 ± 11.5 1.99 (0.08) 3.74 (0.027) 1.27 (0.262) 0.57 (0.565)
pRNFL temporal (µm) 70.1 ± 9.6 70.8 ± 10.3 73.0 ± 7.3 72.4 ± 7.6 78.6 ± 8.7 77.9 ± 7.1 3.2 (0.01) 7.88 (<0.001) 0.01 (0.91) 0.07 (0.929)
pRNFL inferior (µm) 119.4 ± 15.3 121.0 ± 15.1 115.8 ± 11.7 115.2 ± 11.7 119.4 ± 8.0 119.3 ± 10.6 0.7 (0.627) 1.66 (0.195) 0.02 (0.901) 0.08 (0.919)
pRNFL nasal (µm) 73.9 ±11.1 72.0 ± 9.3 75.5 ± 9.0 75.1 ± 10.1 82.4 ± 6.0 79.3 ± 10.0 2.9 (0.017) 6.55 (0.002) 1.01 (0.317) 0.19 (0.828)

In bold: P < 0.05.

ANOVA, analysis of variance; ET, essential tremor; GCL, ganglion cell layer; HC, healthy controls; INL, inner nuclear layer; IPL, inner plexiform layer; ONL, outer nuclear layer; OPL, outer plexiform layer; PD, Parkinson disease; pRNFL, peripapillary RNFL; RNFL, retinal nerve fiber layer; RPE, retinal pigment epithelium.